FDA Inspection 741722 — McGuff Pharmaceuticals, Inc.

McGuff Pharmaceuticals, Inc. — FEI 2022073

The FDA completed an inspection of McGuff Pharmaceuticals, Inc. on Aug 24, 2011 in Santa Ana, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Aug 24, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Santa Ana, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.